American Pharmaceutical(APPX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : American Pharmaceutical(APPX)

APPX 36.58

+5.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who started this subject	8/22/2002 1:14:14 AM
From: ahhaha	of 22

cc by: ahhaha 07/25/02 12:05 pm Msg: 181 of 189 company made good tactical moves by getting into product lines in tight demand with higher margins cost increases due to higher head count and 911 associated insurance costs revising earnings upward from $.52 to $.61 completed 3 phase 1 and 2 phase 2 studies on ABI007. currently in phase 3 and engaged in enrollment for targeted 2003 FDA review. Questions: Should top line hold up? A.(Shiong) Yes. Q. You seem way too conservative. A. Well, we should do at least as well in the second half as the first half. Q. how is the launch of liquid pamidronate progressing? A. pretty good uptick in share from 22% to 31% with GPO contract. Pricing holding up Q. how many new products in second half? A. can't project Q. How will you be switching to new CRO? A. It's a mutli-national trial so our interest was diluted. We've taken the management in hand and got the NDA filing on track for 2003. Q. Progress on ovarian and non-small cell cancers? A. (not much of an answer) Next questioner: Q. Gross margins at 49%? A. Yes. Q. Timing of ABI007 NDA filing. When? A. (Shiong) maybe June Q. NDA filing related to CRO? A. No. Next questioner: Q. How many patients enrolled in ABI007 How is product stocking. A. 200 patients now. timing of follow up: every 3 months. stocking of product: substantially at or above our targets (feel free to make corrections or additions to about)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next